Universe Pharmaceuticals INC
UPC
$2.91
-$0.71-19.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -28.74% | -22.33% | -20.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -28.74% | -22.33% | -20.81% |
| Cost of Revenue | -- | -- | -22.92% | -4.84% | 7.20% |
| Gross Profit | -- | -- | -41.14% | -47.02% | -50.57% |
| SG&A Expenses | -- | -- | 18.70% | -25.63% | -44.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -110.17% | -63.51% | -34.68% |
| Total Operating Expenses | -- | -- | -14.42% | -26.62% | -25.14% |
| Operating Income | -- | -- | -102.21% | 41.39% | 43.65% |
| Income Before Tax | -- | -- | -335.19% | -54.26% | -12.25% |
| Income Tax Expenses | -- | -- | -73.07% | 1,208.48% | 365.93% |
| Earnings from Continuing Operations | -- | -- | -195.38% | -69.59% | -28.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -195.38% | -69.59% | -28.25% |
| EBIT | -- | -- | -102.21% | 41.39% | 43.65% |
| EBITDA | -- | -- | -117.91% | 43.57% | 46.25% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |